Authors:
Abraham, E
Laterre, PF
Garbino, J
Pingleton, S
Butler, T
Dugernier, T
Margolis, B
Kudsk, K
Zimmerli, W
Anderson, P
Reynaert, M
Lew, D
Lesslauer, W
Passe, S
Cooper, P
Burdeska, A
Modi, M
Leighton, A
Salgo, M
Van der Auwera, P
Citation: E. Abraham et al., Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients, CRIT CARE M, 29(3), 2001, pp. 503-510
Authors:
Abraham, E
Reinhart, K
Svoboda, P
Seibert, A
Olthoff, D
Dal Nogare, A
Postier, R
Hempelmann, G
Butler, T
Martin, E
Zwingelstein, C
Percell, S
Shu, V
Leighton, A
Creasey, AA
Citation: E. Abraham et al., Assessment of the safety of recombinant tissue factor pathway inhibitor inpatients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study, CRIT CARE M, 29(11), 2001, pp. 2081-2089